newratings.com  Nov 17  Comment 
PARIS (dpa-AFX) - French drug maker Sanofi (SNYNF.PK, SNY) and its subsidiary Genzyme announced that the U.S. Food and Drug Administration or FDA approved Lemtrada or alemtuzumab for the treatment of patients with relapsing forms of multiple...
Wall Street Journal  Nov 15  Comment 
Sanofi said its U.S. subsidiary Genzyme has received approval from the Food and Drug Administration for its multiple-sclerosis drug Lemtrada.
FierceBiotech  Nov 13  Comment 
One of the primary roles for any Big Pharma CEO is to act as a chief defender of the pipeline. Just months ago, Chris Viehbacher boldly asserted that Sanofi had one of the top 5 pipelines in the industry, if you added in some top programs among...
The Hindu Business Line  Nov 11  Comment 
The board of directors of Sanofi India on Tuesday approved the selling of its commercial premises known as Hoechst House at Nariman Point, Mumbai, to Bright Star Investments and its group c...
StreetInsider.com  Nov 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Regeneron+%28REGN%29%2C+Sanofi+%28SNY%29+Report+Dupilumab+Met+Primary+Endpoint+in+Phase+2b/9998050.html for the full story.
The Hindu Business Line  Nov 11  Comment 
Sanofi India said its board of directors has approved selling its commercial space of five floors and linked car parkings in Hoechst House at Nariman Point, Mumbai, to Bright Star Investments Pvt...
The Hindu Business Line  Nov 10  Comment 
Sanofi Pasteur, the vaccines division of Sanofi, on Monday launched Shan5, its paediatric pentavalent vaccine developed and manufactured by its Indian affiliate Shantha. It is a fully-liq...
Motley Fool  Nov 9  Comment 
Here are three stocks that have gotten crushed lately. Are any of them worth buying?


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki